Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of geldanamycin analogue in treating patients who
have advanced solid tumors or non-Hodgkin's lymphoma. Drugs used in chemotherapy work in
different ways to stop tumor cells from dividing so they stop growing or die.